In a nutshell This study examined accelerated partial breast irradiation (APBI) in comparison to whole breast irradiation (WBI) after surgery. They concluded that survival and long-term side-effects are the same for both treatments. However, ABPI had a higher rate of local recurrence as compared to WBI. Some background For early stage breast...
Read More
“For me, having lost my husband, it’s frustrating to hear publicly people saying to John McCain, ‘If anybody can beat this you can — you’re so tough.’ Not that it’s intentionally hurtful, but it does leave those of us who’ve lost a loved one thinking, ‘Was my loved one not tough enough? Did he not fight hard enough?'” ~Dannagal...
Read More
“I’m barely 27 and if it were not for immunotherapy and cancer research, I would not have seen 25.” So starts Stefanie Joho speech at a 2017 Congressional Hearing called “Progress in Immunotherapy: Delivering Hope and Clinical Benefit to Cancer Patients.” When Stefanie was 22, she was diagnosed with a very aggressive Stage II...
Read More
In a nutshell This study examined whether practicing Tibetan yoga during chemotherapy can benefit sleep quality. This study concluded that practicing twice a week or more led to greater long-term benefits over time. Some background Sleep disturbances and fatigue are common side effects reported by patients undergoing chemotherapy. This can...
Read More
In a nutshell This study examined whether radiotherapy treatment before surgery could improve disease-free survival, especially for patients with estrogen-receptor positive (ER+) breast cancer (dependent on the hormone estrogen for growth). This study concluded that radiotherapy before surgery improved disease-free survival. Some background For...
Read More
You’re at a loss. You’ve just learned your friend or loved one is diagnosed with breast cancer. What do you do? How do you act? What do you say? As I look back at my own actions under these circumstances, I know that I came up short. I said the wrong things and made some basic mistakes. Partly I could blame youth. But mostly I...
Read More
In a nutshell This study aimed to compare the outcomes for patients who received whole and partial breast radiotherapy after undergoing breast conservation surgery. This study concluded that partial breast radiotherapy and lower dose radiotherapy had similar outcomes for patients when compared to whole breast radiotherapy. Some background...
Read More
In a nutshell This study aimed to investigate the effect of therapeutic care for fatigue in breast cancer patients who are undergoing chemotherapy. This study concluded that therapeutic care may decrease fatigue in breast cancer patients undergoing chemotherapy. Some background The standard of care treatment option for breast cancer and...
Read MoreIn a nutshell This study aimed to compare the sexual health of breast cancer survivors to that of women from the general population. This study concluded that breast cancer survivors had poorer sexual health when compared to women from the general population. Some background Post-treatment care is becoming more important in cancer patients...
Read More
Video information: Breast cancer experts gathered at the 2017 American Society of Clinical Oncology meeting to discuss developments in research and treatment. Patient Power founder, Andrew Schorr, was on-site in Chicago and interviewed Dr. Julie Gralow, Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. Dr. Gralow shares...
Read More
From September 8 through 12th, over 24,000 oncologists and oncology researchers attended the European Society of Medical Oncology Meeting (ESMO), the equivalent of the American Society of Clinical Oncology Meeting (ASCO) held in the US. This year’s event focused on connecting researchers to practitioners in a meaningful way. Here are some research...
Read MoreIn a nutshell This study aimed to compare the pathological complete response (pCR) rates of two neoadjuvant therapy combinations for HER2 positive (HER2+, dependent on HER2 for growth) breast cancer. This study concluded that the combination of pertuzumab (Perjeta), trastuzumab (Herceptin) and chemotherapy resulted in higher pCR rates than...
Read More
